Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Melva L. Gonzalez is active.

Publication


Featured researches published by Melva L. Gonzalez.


Microvascular Research | 2003

CAP37, a neutrophil-derived inflammatory mediator, augments leukocyte adhesion to endothelial monolayers

Taunia D Lee; Melva L. Gonzalez; Padmasini Kumar; Paula Grammas

Cationic antimicrobial protein of molecular weight 37 kDa (CAP37) is a multifunctional inflammatory mediator that was originally isolated from human neutrophils and described to possess bactericidal and monocyte-activating functions. More recently its expression in endothelial and epithelial cells in response to inflammatory mediators and its ability to activate endothelial cells and alter permeability has been demonstrated. We hypothesize that CAP37 facilitates the process of transendothelial migration not only because of its potential to act as a chemoattractant but also through its ability to promote leukocyte adhesion to the endothelium by modulating adhesion molecule expression on the endothelium. Here we describe its ability to mediate neutrophil and monocyte adherence to endothelial monolayers in vitro. Using reverse transcriptase-polymerase chain reaction and flow cytometry, we demonstrate its ability to upregulate the adhesion molecules, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in human umbilical vein and lung microvessel endothelial cells. The identity and kinetics of upregulation of the specific adhesion molecule was dependent on the endothelial cell type, suggesting that adhesion molecules on endothelial cells from different vascular beds are differentially regulated by CAP37. The cell-specific kinetics of adhesion molecule upregulation by CAP37 may influence selective leukocyte migration in certain inflammatory situations.


Journal of Immunology | 2000

Glomerular Deposition of Immune Complexes Made with IgG2a Monoclonal Antibodies

Melva L. Gonzalez; Frank J. Waxman

The factors that determine whether immune complexes (IC) are cleared safely from the circulation or are deposited in vulnerable tissues such as glomeruli are not well defined. To better understand how IC are handled, the present study examined the fate in vivo of three model IC preparations with different immunochemical characteristics. Radiolabeled IC were constructed with murine IgG1, IgG2a, or IgG3 anti-DNP mAbs bound to DNP-BSA, designated IgG1 IC, IgG2a IC, and IgG3 IC, respectively. The IC were infused i.v. into BALB/c mice, and clearance and tissue localization of the three IC probes were compared. The results indicate that the major portion of each IC preparation was cleared from the circulation by the liver. However, compared with the other two probes, IgG2a IC were preferentially deposited in the kidney. Histologic examination revealed the presence of IgG2a IC in glomeruli. The enhanced renal uptake of IgG2a IC could not be attributed solely to such characteristics as IC size, Ag/Ab ratio, Ab charge, or affinity. However, the preferential renal deposition of IgG2a IC was abrogated by complement depletion. Thus, enhanced renal uptake in normal mice was complement dependent. These data suggest that interactions between IC and the complement system can influence the propensity of IC to deposit in tissues susceptible to IC-mediated injury.


Investigative Ophthalmology & Visual Science | 2013

CAP37 activation of PKC promotes human corneal epithelial cell chemotaxis.

Gina L. Griffith; Robert A. Russell; Anne Kasus-Jacobi; Elangovan Thavathiru; Melva L. Gonzalez; Sreemathi Logan

PURPOSE The objective of this study was to elucidate the signaling pathway through which cationic antimicrobial protein of 37 kDa (CAP37) mediates human corneal epithelial cell (HCEC) chemotaxis. METHODS Immortalized HCECs were treated with pertussis toxin (10 and 1000 ng/mL), protein kinase C (PKC) inhibitors (calphostin c, 50 nM and Ro-31-8220, 100 nM), phorbol esters (phorbol 12,13-dibutyrate, 200 nM and phorbol 12-myristate 13-acetate, 1 μM) known to deplete PKC isoforms, and siRNAs (400 nM) before a modified Boyden chamber assay was used to determine the effect of these inhibitors and siRNAs on CAP37-directed HCEC migration. PKCδ protein levels, PKCδ-Thr(505) phosphorylation, and PKCδ kinase activity was assessed in CAP37-treated HCECs using immunohistochemistry, Western blotting, and a kinase activity assay, respectively. RESULTS Chemotaxis studies revealed that treatment with pertussis toxin, PKC inhibitors, phorbol esters, and siRNAs significantly inhibited CAP37-mediated chemotaxis compared with untreated controls. CAP37 treatment increased PKCδ protein levels and led to PKCδ phosphorylation on residue Thr(505). Direct activation of PKCδ by CAP37 was demonstrated using a kinase activity assay. CONCLUSIONS These findings lead us to conclude that CAP37 is an important regulator of corneal epithelial cell migration and mediates its effects through PKCδ.


Molecular Immunology | 2003

Structural analysis of IgG2A monoclonal antibodies in relation to complement deposition and renal immune complex deposition.

Melva L. Gonzalez; Mark Barton Frank; Paul A. Ramsland; Jay S. Hanas; Frank J. Waxman

This study explores the structural features of murine monoclonal IgG2a anti-dinitrophenyl (DNP) antibodies that were previously shown to form immune complexes (IC) differing in their capacity to bind complement, their clearance from the circulation and their deposition in the kidney. Interestingly, the sequence of one of these antibodies has a missing stretch of 14 amino acids within FR3. Molecular modeling suggests that this sequence deletion corresponds to the loss of beta-pleated sheet structure for two beta-strands (designated 4-3 and 4-4) on the external surface of the V(H) domain. Despite this sequence and conformational abnormality, the antibody retains affinity for DNP comparable to other IgG2a antibodies. Data presented here identify monoclonal IgG2a antibodies that form IC with varying propensity for both complement binding and renal deposition and yet have similar V(H) domain sequences. In fact, in the case of two IgG2a antibodies that form IC with very different renal tropisms and complement binding capacity, sequence variation within V(H) was observed only at three clustered residues within FR2, a single residue within FR3 and nine clustered residues spanning CDR3 and FR4. Sequence and modeling analysis also yielded the paradoxical finding that an antibody forming IC with a relatively high capacity to serve as a target for complement binding displays a relatively low number of solvent exposed acceptor residues for C4b and C3b. These data underscore the complex relationship between V domain structure, complement activation and renal deposition of model IC.


Investigative Ophthalmology & Visual Science | 2004

Modulation of corneal epithelial cell functions by the neutrophil-derived inflammatory mediator CAP37.

Xin Ruan; Melva L. Gonzalez; Irina Tsyshevskaya-Hoover; James Chodosh


Microvascular Research | 2004

Functional modulation of smooth muscle cells by the inflammatory mediator CAP37

Melva L. Gonzalez; Xin Ruan; Padmasini Kumar; Paula Grammas


Clinical Immunology | 2001

Relationship between Complement Activation and Renal Deposition of Immune Complexes Made with IgG2a Monoclonal Antibodies

Melva L. Gonzalez; Frank J. Waxman


Archive | 2002

Its Expression in Endothelial Cells and Localization to Atherosclerotic Lesions

Taunia D. Lee; Melva L. Gonzalez; Padmasini Kumar; Saritha Chary-Reddy; Paula Grammas


Journal of Immunology | 2007

Monoclonal antibodies to HLA class I restricted influenza epitopes

Melva L. Gonzalez; Angela Wahl; William H. Hildebrand


Journal of Immunology | 2007

Viral and Self HLA Class I Peptides Mark the Surface of Influenza Infected Cells

Angela Wahl; Fredda Schafer; Wilfried Bardet; Rico Buchli; Malaroviyam Samikkannu; Annette Fleshman; Melva L. Gonzalez; Gillian M. Air; William H. Hildebrand

Collaboration


Dive into the Melva L. Gonzalez's collaboration.

Top Co-Authors

Avatar

William H. Hildebrand

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

Angela Wahl

University of Oklahoma

View shared research outputs
Top Co-Authors

Avatar

Frank J. Waxman

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

Padmasini Kumar

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

Paula Grammas

Texas Tech University Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

Annette Fleshman

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

Oriana Hawkins

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

Rico Buchli

University of Oklahoma

View shared research outputs
Top Co-Authors

Avatar

Wilfried Bardet

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

Xin Ruan

University of Oklahoma Health Sciences Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge